Tallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac’s pipeline of immunotherapy candidates are derived from the company’s novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform to deliver a potent Toll-like receptor (TLR9) agonist (T-CpG) for targeted immune activation via systemic administration. Several TRAAC molecules are in various stages of discovery and preclinical development.
View Top Employees from Tallac Therapeutics| Website | https://www.tallactherapeutics.com |
| Employees | 29 (29 on RocketReach) |
| Address | 866 Malcom Rd Suite 100, Burlingame, California, US |
| Technologies |
JavaScript,
HTML,
PHP
+2 more
(view full list)
|
| Industry | Biotechnology Research |
Looking for a particular Tallac Therapeutics employee's phone or email?
Tallac Therapeutics Questions
Hong Wan is the President, Chief Executive Officer and Co-Founder of Tallac Therapeutics.
29 people are employed at Tallac Therapeutics.
Tallac Therapeutics is based in Burlingame, California.
Top Tallac Therapeutics Employees
-
ViewHong Wan
President, Chief Executive Officer and Co-Founder at Tallac Therapeutics
California, United States45+ -
15+
-
5+2
-
View
Janet 沈彬
VP Biologics Discovery and Development at Tallac Therapeutics
San Francisco, California, United States35+ -
ViewBora Han
Vice President, Preclinical Development at Tallac Therapeutics
San Francisco, California, United States42 -
24
-
12
-
ViewMaria Costa
Senior Director, Head of Biology and Translational Research at Tallac Therapeutics
San Francisco, CA, US15+ -
ViewCandy Bermingham
Vice President of Clinical Science at Tallac Therapeutics
Oakland, California, United States12
Related Companies
